Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Calcif Tissue Int ; 74(6): 509-15, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15354858

RESUMEN

We investigated the relationships between tumor necrosis factor (TNF) gene polymorphism, circulating TNF-alpha (TNF-alpha) concentrations, and bone mineral density (BMD) in the lumbar spine. TNF gene polymorphisms studied were the Nco I polymorphism within the first intron of TNF-beta (TNF-beta) and three single nucleotide polymorphisms in the promoter region of the TNF-alpha gene, at positions -857, -863, and -1031. Allelic variants of the TNF gene were identified using restriction fragment length polymorphism (RFLP) analysis in 177 postmenopausal Japanese women within 10 years after menopause, aged 56.4 +/- 4.5 years (mean +/- SD). A significantly higher prevalence of the alleles TNF-alpha-863A (20.3% versus 9.9%) and TNF-alpha-1031C (21.3% versus 12.4%) was seen in the low BMD group (Z-score < 0, n = 91) than in the high BMD group (0 < Z-score, n = 86). In genotype analysis, although difference did not reach a significant level, women with the rarest allelic variants, i.e., homozygous TNFbl, TNF-alpha-863A, and TNF-alpha-1031C, showed the lowest BMD Z-scores. Women with another rarest allelic variant, TNF-alpha-857T/T had significantly lower BMD Z-scores than did women with TNF-alpha-857C/T or -857C/C. The BMD Z-score decreased significantly with an increase in the total number of such rare alleles. Serum concentrations of TNF-alpha did not differ significantly among groups divided by genotypes. Multiple linear regression analysis revealed that the total number of rare alleles, in addition to the body mass index and the number of years since menopause, was an independent predictor of the BMD. These presumptive functional polymorphisms of the TNF gene may be associated with the lumbar spine BMD in early postmenopausal Japanese women.


Asunto(s)
Pueblo Asiatico , Densidad Ósea/genética , Vértebras Lumbares/metabolismo , Polimorfismo de Nucleótido Simple , Posmenopausia , Factor de Necrosis Tumoral alfa/genética , Absorciometría de Fotón , Cartilla de ADN/química , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Japón/epidemiología , Desequilibrio de Ligamiento , Linfotoxina-alfa/genética , Persona de Mediana Edad , Osteoporosis Posmenopáusica/epidemiología , Osteoporosis Posmenopáusica/genética , Reacción en Cadena de la Polimerasa , Polimorfismo de Longitud del Fragmento de Restricción , Factor de Necrosis Tumoral alfa/metabolismo
2.
Biochem Biophys Res Commun ; 281(3): 663-9, 2001 Mar 02.
Artículo en Inglés | MEDLINE | ID: mdl-11237709

RESUMEN

The protooncogene Pim-1 encodes serine/threonine protein kinases that are involved in cytokine-mediated cell proliferation and in lymphoma- and leukemogenesis. It is largely unknown how Pim-1 executes its biological effects. Here we show that Pim-1 physically interacts with heat shock protein 90 alpha and beta (Hsp90alpha and beta). The Hsp90-specific inhibitor geldanamycin (GA) induced a rapid degradation of Pim-1 and reduced its kinase activity. The expression of Hsp90alpha was regulated by a signal from the cytokine receptor gp130, as is Pim-1's expression. These results indicate that Hsp90 is coordinately regulated with Pim-1 and is involved in the stabilization and function of Pim-1.


Asunto(s)
Regulación de la Expresión Génica/fisiología , Proteínas HSP90 de Choque Térmico/fisiología , Proteínas Serina-Treonina Quinasas , Proteínas Proto-Oncogénicas/genética , Secuencia de Aminoácidos , Antígenos CD/metabolismo , Secuencia de Bases , Línea Celular , Receptor gp130 de Citocinas , Cartilla de ADN , Proteínas de Unión al ADN/metabolismo , Glicoproteínas de Membrana/metabolismo , Datos de Secuencia Molecular , Proteínas Proto-Oncogénicas c-pim-1 , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factor de Transcripción STAT3 , Transducción de Señal , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Transactivadores/metabolismo
3.
Growth Factors ; 17(2): 81-91, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10595309

RESUMEN

Cytokines play roles in a wide range of responses such as immune response, hematopoiesis and inflammation. A large volume of studies revealed that cytokines show functional pleiotropy and redundancy. Gp130 is a receptor subunit shared by the interleukin-6 family of cytokines. We describe and discuss signaling through gp130 in relation to a general scenario for cytokine signaling regulating cell growth, differentiation and survival.


Asunto(s)
Antígenos CD/fisiología , Glicoproteínas de Membrana/fisiología , Transducción de Señal/fisiología , Animales , Receptor gp130 de Citocinas , Humanos , Modelos Biológicos
4.
Blood ; 93(6): 1809-16, 1999 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-10068651

RESUMEN

We previously found that the adapter protein Gab1 (110 kD) is tyrosine-phosphorylated and forms a complex with SHP-2 and PI-3 kinase upon stimulation through either the interleukin-3 receptor (IL-3R) or gp130, the common receptor subunit of IL-6-family cytokines. In this report, we identified another adapter molecule (100 kD) interacting with SHP-2 and PI-3 kinase in response to various stimuli. The molecule displays striking homology to Gab1 at the amino acid level; thus, we named it Gab2. It contains a PH domain, proline-rich sequences, and tyrosine residues that bind to SH2 domains when they are phosphorylated. Gab1 is phosphorylated on tyrosine upon stimulation through the thrombopoietin receptor (TPOR), stem cell factor receptor (SCFR), and T-cell and B-cell antigen receptors (TCR and BCR, respectively), in addition to IL-3R and gp130. Tyrosine phosphorylation of Gab2 was induced by stimulation through gp130, IL-2R, IL-3R, TPOR, SCFR, and TCR. Gab1 and Gab2 were shown to be substrates for SHP-2 in vitro. Overexpression of Gab2 enhanced the gp130 or Src-related kinases-mediated ERK2 activation as that of Gab1 did. These data indicate that Gab-family molecules act as adapters for transmitting various signals.


Asunto(s)
Proteínas de Neoplasias , Fosfoproteínas/metabolismo , Receptores de Citocinas , Proteínas Adaptadoras Transductoras de Señales , Secuencia de Aminoácidos , Animales , Antígenos CD/fisiología , Línea Celular , Receptor gp130 de Citocinas , Expresión Génica , Humanos , Péptidos y Proteínas de Señalización Intracelular , Glicoproteínas de Membrana/fisiología , Ratones , Datos de Secuencia Molecular , Fosfatidilinositol 3-Quinasas/metabolismo , Fosfoproteínas/química , Fosfoproteínas/genética , Fosforilación , Proteína Tirosina Fosfatasa no Receptora Tipo 11 , Proteína Tirosina Fosfatasa no Receptora Tipo 6 , Proteínas Tirosina Fosfatasas/metabolismo , Proteínas Proto-Oncogénicas/fisiología , Proteínas Proto-Oncogénicas c-kit/fisiología , Receptores de Antígenos de Linfocitos B/fisiología , Receptores de Antígenos de Linfocitos T/fisiología , Receptores de Interleucina-3/fisiología , Receptores de Trombopoyetina , Transducción de Señal , Tirosina/metabolismo
5.
Immunity ; 11(6): 709-19, 1999 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-10626893

RESUMEN

The activation of STAT3 by the cytokine receptor gp130 is required for both the G1 to S cell cycle transition and antiapoptosis. We found that Pim-1 and Pim-2 are targets for the gp130-mediated STAT3 signal. Expression of a kinase-defective Pim-1 mutant attenuated gp130-mediated cell proliferation. Constitutive expression of Pim-1 together with c-myc, another STAT3 target, fully compensated for loss of the STAT3-mediated cell cycle progression, antiapoptosis, and bcl-2 expression. We also identified valosine-containing protein (VCP) as a target gene for the Pim-1-mediated signal. Expression of a mutant VCP led cells to undergo apoptosis. These results indicate that Pim-family proteins play crucial roles in gp130-mediated cell proliferation and explain the synergy between Pim and c-Myc proteins in cell proliferation and lymphomagenesis.


Asunto(s)
Apoptosis , Ciclo Celular/fisiología , Proteínas de Unión al ADN/metabolismo , Proteínas Serina-Treonina Quinasas , Proteínas Proto-Oncogénicas c-myc/fisiología , Proteínas Proto-Oncogénicas/fisiología , Transducción de Señal , Transactivadores/metabolismo , Adenosina Trifosfatasas , Animales , Antígenos CD/genética , Antígenos CD/metabolismo , Linfocitos B/citología , Proteínas de Ciclo Celular/metabolismo , Línea Celular , Receptor gp130 de Citocinas , Humanos , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/metabolismo , Ratones , Proteínas Proto-Oncogénicas/genética , Proteínas Proto-Oncogénicas/metabolismo , Proteínas Proto-Oncogénicas c-myc/genética , Proteínas Proto-Oncogénicas c-pim-1 , Factor de Transcripción STAT3 , Células Tumorales Cultivadas , Proteína que Contiene Valosina
6.
EMBO J ; 17(22): 6670-7, 1998 Nov 16.
Artículo en Inglés | MEDLINE | ID: mdl-9822610

RESUMEN

The signal transducer and activator of transcription molecules (STATs) play key roles in cytokine-induced signal transduction. However, their role in cell growth has not been clear. In the present study, we show that STAT3 plays a key role in the G1 to S phase cell-cycle transition induced by the cytokine receptor subunit gp130, through the upregulation of cyclins D2, D3 and A, and cdc25A, and the concomitant downregulation of p21 and p27. Furthermore, unexpectedly, we found that gp130 could induce the expression of p21 when STAT3 activation was suppressed. Such contradictory signals regulating cell-cycle progression could be simultaneously delivered from distinct cytoplasmic regions of gp130. We propose an 'orchestrating model' for cytokine and growth factor action in which contradictory signals are orchestrated to produce a specific effect in a target cell.


Asunto(s)
Citocinas/farmacología , Proteínas de Unión al ADN/metabolismo , Fase G1/efectos de los fármacos , Fase S/efectos de los fármacos , Transducción de Señal , Transactivadores/metabolismo , Línea Celular , Quinasas Ciclina-Dependientes/antagonistas & inhibidores , Quinasas Ciclina-Dependientes/metabolismo , Regulación hacia Abajo , Activación Enzimática , Inhibidores Enzimáticos/farmacología , Factor de Transcripción STAT3
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA